Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Consulte a su mdico y/o farmacutico
doi: 10.1111/dom.12885 Summary Keywords lipodystrophy, glucagon-like peptide-1, diabetes, seipin, liraglutide Citation Roumane A, Mcilroy GD, Sommer N, Han W, Heisler LK and Rochford JJ (2024) GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy
Key features Functionally validated using proprietary incretin-bioassays High purity and guaranteed sterile Tested for hormone receptor specificity Endotoxin tested Since these metabolic hormones are biologically active molecules, their functions cant be fully understood through physicochemical analyses alone
Albiglutide: A New GLP-1 Receptor Agonist Option
US$ 20.03
US$ 28.80
US$ 26.48
US$ 28.81
US$ 25.54
